INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 143 filers reported holding INFINITY PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 2.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $1,000 | -99.8% | 400 | -99.2% | 0.00% | -100.0% |
Q3 2015 | $444,000 | +76.9% | 52,540 | +129.4% | 0.00% | – |
Q2 2015 | $251,000 | -45.9% | 22,905 | -31.0% | 0.00% | -100.0% |
Q1 2015 | $464,000 | -70.3% | 33,201 | -64.1% | 0.00% | -50.0% |
Q4 2014 | $1,561,000 | +10306.7% | 92,384 | +7598.7% | 0.00% | – |
Q2 2014 | $15,000 | -96.2% | 1,200 | -96.4% | 0.00% | – |
Q1 2014 | $395,000 | -51.4% | 33,200 | -43.5% | 0.00% | -100.0% |
Q4 2013 | $812,000 | – | 58,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 6,575,000 | $21,237,000 | 2.26% |
AIGH Capital Management LLC | 1,650,256 | $5,330,000 | 1.12% |
BVF INC/IL | 8,383,645 | $27,079,000 | 1.02% |
GUARDIAN POINT CAPITAL, LP | 1,200,000 | $3,876,000 | 0.97% |
Tri Locum Partners LP | 1,210,863 | $3,911,000 | 0.97% |
Altium Capital Management LP | 972,327 | $3,141,000 | 0.87% |
Worth Venture Partners, LLC | 387,141 | $1,250,000 | 0.61% |
DAFNA Capital Management LLC | 459,260 | $1,483,000 | 0.35% |
SABBY MANAGEMENT, LLC | 530,000 | $1,712,000 | 0.33% |
KNIGHTSBRIDGE ASSET MANAGEMENT, LLC | 173,110 | $559,000 | 0.24% |